{
    "organizations": [],
    "uuid": "d8b656046b66c1a9622856efe6a05828fa6eb49b",
    "author": "",
    "url": "https://www.reuters.com/article/brief-melinta-therapeutics-q4-loss-per-s/brief-melinta-therapeutics-q4-loss-per-share-1-48-idUSASC09RYG",
    "ord_in_thread": 0,
    "title": "BRIEF-Melinta Therapeutics Q4 Loss Per Share $1.48",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "  in 7 minutes BRIEF-Melinta Therapeutics Q4 Loss Per Share $1.48 Reuters Staff   Melinta Therapeutics, Inc.: * MELINTA THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS * Q4 LOSS PER SHARE $1.48 * Q4 EARNINGS PER SHARE VIEW $-0.76 — THOMSON REUTERS I/B/E/S * MELINTA THERAPEUTICS - ‍AS OF DEC 31, 2017, HAD CASH AND CASH EQUIVALENTS OF $128.4 MILLION​  ",
    "published": "2018-03-13T13:09:00.000+02:00",
    "crawled": "2018-03-13T13:21:36.006+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "minute",
        "therapeutic",
        "q4",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "melinta",
        "therapeutic",
        "melinta",
        "therapeutic",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "q4",
        "loss",
        "per",
        "share",
        "q4",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "melinta",
        "therapeutic",
        "dec",
        "cash",
        "cash",
        "equivalent"
    ]
}